Located at 40 Panduri Road, District 5, the new facility provides patients with access to integrated medical services, including laboratory testing, specialist consultations, and functional monitoring. In addition, the newly opened unit has incorporated the operations of the former MedLife Panduri clinic, which previously served patients in the area.
With this opening, MedLife now operates 37 hyperclinics nationwide, including eight in Bucharest, further strengthening its position as the leader in Romania’s private healthcare market.
“The opening of a new large-scale facility in Bucharest is a natural step in our development strategy and responds to patients’ growing need for access to a comprehensive portfolio of medical services closer to home. Through our network of hyperclinics across the capital, we are now able to be even closer to our patients and provide fast access to integrated healthcare services, regardless of where they are located. The new hyperclinic has been developed according to the one-stop-shop model, offering convenient access to a wide range of medical specialties, laboratory testing, and advanced technologies,” said Dorin Preda, Deputy Chief Executive Officer, MedLife Group.
The MedLife Panduri Hyperclinic spans approximately 1,000 square meters across three floors and features 16 consultation rooms, a minor procedures room, and a dedicated sample collection unit for laboratory testing. Patients have access to 27 medical specialties, including obstetrics and gynaecology, internal medicine, rheumatology, diabetes and nutrition, neurology, cardiology, endocrinology, oncology, nephrology, and many others. The diagnostic services are supported by modern medical technology and multidisciplinary teams with both national and international expertise.
By integrating services available on both a fee-for-service basis and through corporate healthcare subscription plans, the new hyperclinic expands access to comprehensive medical care for residents of Bucharest and the surrounding areas.
The company ended Q1/2026 with RON853 million consolidated turnover, up almost 10% from the year-earlier period, and 17% lower net profit of RON8.8 million.
The company’s shares have gained 88% in the past year amid RON6.6 billion capitalization.
(English version by Catalina Apostoiu)